NSAIDs Market Report 2025 (Global Edition)

Global NSAIDs Market Report 2024 Market Size Split by End Use Outlook: (Back Pain Treatment, Osteoarthritis Treatment, Other Disease Treatment), by Administration Outlook: (Oral, Topical, Others), by ...

NSAIDs Market Report Description

We have various report editions of NSAIDs Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

NSAIDs Market Insights Video

Competitive Landscape of the NSAIDs Market

The NSAIDs market is highly competitive, with numerous global players offering a wide range of products. Companies such as Pfizer, Johnson & Johnson, and Bayer dominate the market with established brands like Advil, Aleve, and Aspirin. Competition is based on factors such as product innovation, safety profiles, pricing, and distribution networks. Emerging companies are focusing on developing safer, more effective NSAID formulations, while larger companies maintain their leadership through strong brand recognition and extensive distribution channels.

In February 2024, Hikma Pharmaceuticals introduced COMBOGESIC IV in the U.S., offering an opioid-free alternative for adult pain management. COMBOGESIC IV combines acetaminophen (1,000 mg) and ibuprofen (300 mg) for intravenous use, receiving FDA approval in October 2023 for treating mild to moderate pain, with an adjunctive role in severe pain alongside opioids. This dual-action solution aligns with the American Society of Anesthesiology’s multimodal pain management strategy, offering quicker and sustained pain relief. Developed by AFT Pharmaceuticals, COMBOGESIC IV is also marketed globally as MAXIGESIC IV. (Source: https://www.hikma.com/news/hikma-announces-us-launch-of-combogesic-iv/) In December 2023, Scilex Holding Company submitted a New Drug Submission to Health Canada for ELYXYB (celecoxib oral solution), intended to treat acute migraines. ELYXYB is the only FDA-approved oral solution for migraines, offering pain relief within 15 minutes. With the Canadian migraine therapeutics market expected to reach USD 400 million by 2025, Scilex anticipates approval within a year. The company aims to provide an alternative for patients who are not responsive to triptan therapies. (Source: https://scilexholding.gcs-web.com/news-releases/news-release-details/scilex-holding-company-announces-filing-new-drug-submission-nds)

Top Companies Market Share in NSAIDs Industry: (In no particular order of Rank)

• Pfizer Inc.
• Johnson & Johnson
• Novartis AG
• GlaxoSmithKline plc
• Bayer AG
• Sanofi S.A.
• Abbott Laboratories
• Merck & Co.
• Inc.
• Amgen Inc.
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Cipla Limited
• Sun Pharmaceutical Industries Ltd.
• Mallinckrodt Pharmaceuticals
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the NSAIDs Market

Which Region Dominates the NSAIDs Market in 2024?

According to Cognitive Market Research, North America is the largest market for NSAIDs, driven by the high prevalence of chronic pain conditions like arthritis and back pain. The region benefits from well-established healthcare infrastructure, widespread access to over-the-counter NSAIDs, and a strong demand for prescription-based therapies. Additionally, increasing awareness of pain management options and the aging population contribute to the growth of the NSAIDs market in this region. The presence of key players and advanced healthcare systems further solidifies North America's dominance in the market.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is the fastest-growing region in the NSAIDs market, primarily due to rapid urbanization, growing healthcare access, and rising awareness about pain management. The region's expanding geriatric population, particularly in countries like China and India, is contributing to an increased prevalence of chronic conditions that require pain management. Additionally, the rising availability of affordable NSAIDs through both offline and online pharmacies is driving market expansion. As healthcare systems continue to improve, the demand for NSAIDs is expected to surge in Asia-Pacific.

The current report Scope analyzes NSAIDs Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America NSAIDs

According to Cognitive Market Research, the global NSAIDs market size was estimated at USD 18542.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 7417.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.

• According to Cognitive Market Research, The United States NSAIDs market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 5852.01 million in 2024. The demand for NSAIDs in the U.S. will rise due to increasing prevalence of chronic pain, aging population, and healthcare advancements.
• The Canada NSAIDs market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 890.04 million in 2024. In Canada, growing awareness of pain management solutions and a rising number of patients with musculoskeletal conditions will drive NSAIDs sales. The Mexico NSAIDs market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 674.95 million in 2024.

Europe NSAIDs

According to Cognitive Market Research, the global NSAIDs market size was estimated at USD 18542.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 5562.75 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.

• The United Kingdom NSAIDs market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 934.54 million in 2024. In the UK, higher adoption of over-the-counter pain relievers and more personalized healthcare approaches are propelling the NSAIDs market growth.
• The France NSAIDs market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 511.77 million in 2024. The Germany NSAIDs market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 1101.42 million in 2024. Germany’s advanced healthcare infrastructure and increasing arthritis cases will boost NSAIDs usage as patients seek effective pain relief treatments. The Italy NSAIDs market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 478.40 million in 2024. The Russia NSAIDs market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 862.23 million in 2024. The Spain NSAIDs market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 456.15 million in 2024. The Luxembourg NSAIDs market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 172.45 million in 2024. The Portugal NSAIDs market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 116.82 million in 2024. The Greece NSAIDs market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 66.75 million in 2024. The Rest of Europe NSAIDs market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 862.23 million in 2024.

Asia Pacific NSAIDs

According to Cognitive Market Research, the global NSAIDs market size was estimated at USD 18542.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 4264.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

• According to Cognitive Market Research, China NSAIDs market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 1919.15 million in 2024. China's expanding elderly population and rising awareness about pain management solutions are key drivers of NSAID demand in the region.
• The Japan NSAIDs market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 588.54 million in 2024. The India NSAIDs market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 511.77 million in 2024. In India, increasing healthcare accessibility and the demand for affordable pain relief solutions among the growing middle class fuel NSAIDs sales. The South Korea NSAIDs market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 426.48 million in 2024. The Australia NSAIDs market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 221.77 million in 2024. The South East Asia NSAIDs market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 294.27 million in 2024. The Rest of Asia Pacific NSAIDs market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 302.80 million in 2024.

South America NSAIDs

According to Cognitive Market Research, the global NSAIDs market size was estimated at USD 18542.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 927.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

• According to Cognitive Market Research, Brazil NSAIDs market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 396.81 million in 2024. Brazil’s increasing prevalence of joint-related disorders and improving healthcare infrastructure contribute to the growing demand for NSAIDs in the market.
• The Argentina NSAIDs market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 155.76 million in 2024. In Argentina, rising awareness of pain management and the growing number of elderly patients will drive higher sales of NSAIDs. The Colombia NSAIDs market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 82.51 million in 2024. The Peru NSAIDs market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 76.02 million in 2024. The Chile NSAIDs market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 66.75 million in 2024. The Rest of Latin America NSAIDs market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 149.27 million in 2024.

Middle East and Africa NSAIDs

According to Cognitive Market Research, the global NSAIDs market size was estimated at USD 18542.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 370.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• The GCC Countries NSAIDs market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 158.72 million in 2024. Rising healthcare spending, a growing elderly population, and increasing healthcare awareness in GCC countries are expected to fuel NSAIDs sales growth.
• The Egypt NSAIDs market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 38.94 million in 2024. The South Africa NSAIDs market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 58.59 million in 2024. In South Africa, the rising prevalence of chronic diseases and increasing healthcare accessibility will result in growing demand for NSAIDs. The Turkey NSAIDs market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 31.89 million in 2024. The Nigeria NSAIDs market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 38.94 million in 2024. The Rest of MEA NSAIDs market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 43.76 million in 2024.

NSAIDs Market Analysis

Segment Analysis of NSAIDs Market

Based on present and future trends, the market size is estimated from 2019 to 2031. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for NSAIDs market.

of NSAIDs analyzed in this report are as follows:

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of NSAIDs Industry. Request a Free Sample PDF!

Segment Analysis of NSAIDs Market

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of NSAIDs from 2019 to 2031. This will also help to analyze the demand for NSAIDs across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.

Some of the key of NSAIDs are:

The above Graph is for representation purposes only. This chart does not depict actual Market share.

NSAIDs End Use Outlook: Segment Analysis

NSAIDs Market End Use Segment Analysis

According to Cognitive Market Research, the osteoarthritis treatment segment holds the largest share of the market due to the widespread prevalence of the condition, particularly among older adults. NSAIDs are commonly prescribed to manage chronic pain and inflammation associated with osteoarthritis. The growing aging population and increasing awareness about pain management options are driving the continued demand for NSAIDs in osteoarthritis treatment.

In the NSAIDs market, the back pain treatment has been expanding at a rapid pace due to the high incidence of musculoskeletal disorders and sedentary lifestyles. NSAIDs, particularly ibuprofen and naproxen, are often the first line of treatment for back pain due to their anti-inflammatory and analgesic properties. As more people seek effective and affordable pain relief options, the demand for NSAIDs in back pain management is increasing.

• Back Pain Treatment
• Osteoarthritis Treatment
• Other Disease Treatment

NSAIDs Administration Outlook: Segment Analysis

NSAIDs Market Administration Segment Analysis

According to Cognitive Market Research, the oral segment holds the largest share of the market because of the convenience, ease of use, and effectiveness of oral NSAIDs in treating various pain conditions. With wide availability and affordability, oral NSAIDs like ibuprofen and naproxen are often the preferred choice for patients seeking quick relief from pain. The growing preference for self-medication and OTC availability further drives the dominance of this segment.

In the NSAIDs market, the topical has been expanding at a rapid pace due to the increasing demand for localized pain relief with fewer systemic side effects. Topical formulations, such as gels and creams, allow targeted treatment for conditions like arthritis and muscle pain without the gastrointestinal risks associated with oral NSAIDs. As awareness of these benefits grows, more consumers are opting for topical NSAIDs for pain management.

• Oral
• Topical
• Others

NSAIDs Distribution Channel Outlook: Segment Analysis

NSAIDs Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the hospital pharmacy segment holds the largest share of the market due to the high demand for NSAIDs in clinical settings for acute pain management and post-surgical recovery. Hospitals rely on prescription NSAIDs for effective pain relief, particularly for patients with conditions such as arthritis or injuries. The growing number of hospitalizations and healthcare access contribute to the consistent demand in this segment.

In the NSAIDs market, the online pharmacy has been expanding at a rapid pace due to the growing trend of e-commerce and increasing consumer preference for convenience. Online pharmacies offer easier access to NSAIDs, particularly for those seeking over-the-counter pain relief or refills. With the rise of digital health platforms and home delivery services, more consumers are opting for online purchases, driving growth in this segment.

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion